Recent Posts on This Topic | See All >
[Source: GEN] - With ongoing advances in genomic technologies, clinicians are eager to move personalized medicine from the realm of theory to practice. Investigating whether the technology is mature enough, and if so, how to implement it, has become a hot topic of discussion in the field of personalized medicine.
Thus far, some of the most clinic-ready technology exists in the field of pharmacogenomics, where genes have been linked to drug efficacy, toxicity, and dosing. In addition to practical considerations regarding science and patient care, scientists are now tackling the thorny issues of policy and ethics.
The “Personalized Medicine in the Clinic” meeting held recently at Arizona State University in Phoenix featured dual tracks for discussing both the science and policy implications of the latest pharmacogenomic advances.
For more information: Pharmacogenomics on Its Way Toward Clinic
“Arizona’s Bioscience Roadmap 2014-2025: Advancing the Biosciences and Improving Health Outcomes,” is available along with its supplement, “Summary of Goals, Strategies, and Potential Actions.” The updated Roadmap provides a long-term strategy for Arizona to achieve bioscience success over the next decade. Also, discover The State of Bioscience.